Rules-Based Medicine (RULE)

IPO News
Latest User Comments
Business
  • Develops and commercializes molecular diagnostic tests based on novel biomarker patterns.
  • Health-Products
  • 124
  • 2002
IPO Profile
  • TBA
  • 12/23/09
  • $90.0 mm
  • $0 - $0
  • n/a
  • Jefferies & Co.
  • Stephens Inc.

  • All Underwriters
RULE Daily
Week Month Quarter 1 Year
 
Corporate Data